Cel Sci (CVM) Shares Outstanding (2010 - 2026)
Cel Sci (CVM) posted Shares Outstanding of 1.8 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from 1.8 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Shares Outstanding (2010 - 2026) Analysis & Trends
Since fiscal Q3 2010, Cel Sci has reported Shares Outstanding for 65 quarters.
- Annual Shares Outstanding shows a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
- In prior fiscal years, Cel Sci's Shares Outstanding was 1.8 million in FY2024 (+21.4%), 1.48 million in FY2023 (+3.1%), 1.44 million in FY2022 (+6.0%) and 1.36 million in FY2021 (+10.7%).
- On a year-over-year basis, Shares Outstanding increased in three of the last eight quarters, with growth averaging 4.6%.
- Over the past five years, the year-over-year growth in Shares Outstanding ranged from 0.0% (fiscal Q3 2025) to 22.0% (fiscal Q3 2024).
- According to Business Quant data, Shares Outstanding for the three prior fiscal quarters was 1.8 million (Q2 2026), 1.8 million (Q1 2026) and 1.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Cel Sci | 3.22 Mn | -22.43 Mn | - | 1.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.45 Mn |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.36 Mn |
API Access
Cel Sci Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();